V. Kalotychou

发表

Correlation of Fc-γ RIIA polymorphisms with latent Epstein–Barr virus infection and latent membrane protein 1 expression in patients with low grade B-cell lymphomas

M. Angelopoulou, E. Terpos, P. Kollia, 2013, Leukemia & lymphoma.

Hydroxyurea Therapy in Thalassemia a

D. Loukopoulos, E. Voskaridou, V. Kalotychou, 1998, Annals of the New York Academy of Sciences.

Empagliflozin Attenuates Non-Alcoholic Fatty Liver Disease (NAFLD) in High Fat Diet Fed ApoE(-/-) Mice by Activating Autophagy and Reducing ER Stress and Apoptosis

H. Randeva, C. Mantzoros, A. Papavassiliou, 2021, International journal of molecular sciences.

Reduced peripheral blood superoxide dismutase 2 expression in sickle cell disease

I. Moyssakis, K. Konstantopoulos, I. Armenis, 2019, Annals of Hematology.

Prognostic value of T786C and G894T eNOS polymorphisms in sickle cell disease.

P. Kollia, K. Pantos, K. Konstantopoulos, 2017, Nitric oxide : biology and chemistry.

Assessment of oxidative stress in patients with sickle cell disease: The glutathione system and the oxidant-antioxidant status.

I. Papassotiriou, E. Kanavakis, F. Apostolakou, 2011, Blood cells, molecules & diseases.

Polymorphisms of uridine glucuronosyltransferase gene and irinotecan toxicity: low dose does not protect from toxicity

K. Konstantopoulos, N. Tsavaris, I. Armenis, 2014, Ecancermedicalscience.

The impact of the mutations of the HFE gene and of the SLC11A3 gene on iron overload in Greek thalassemia intermedia and beta(s)/beta(thal) anemia patients.

G. Papanikolaou, M. Politou, V. Kalotychou, 2004, Haematologica.

Reduction of the clinical severity of sickle cell/beta-thalassemia with hydroxyurea: the experience of a single center in Greece.

D. Loukopoulos, E. Voskaridou, I. Theodoropoulos, 2000, Blood cells, molecules & diseases.

Clinical and laboratory effects of long‐term administration of hydroxyurea to patients with sickle‐cell/β‐thalassaemia

D. Loukopoulos, E. Voskaridou, V. Kalotychou, 1995 .

Clinical and laboratory effects of long-term administration of hydroxyurea to patients with sickle-cell/beta-thalassaemia.

D. Loukopoulos, E. Voskaridou, V. Kalotychou, 1995, British journal of haematology.

Systolic and diastolic function in middle aged patients with sickle β thalassaemia. An echocardiographic study

I. Moyssakis, D. Papadopoulos, V. Kalotychou, 2005, Postgraduate Medical Journal.

Estrogen Receptor Subtypes Elicit a Distinct Gene Expression Profile of Endothelial-Derived Factors Implicated in Atherosclerotic Plaque Vulnerability

H. Randeva, A. Papavassiliou, K. Dahlman-Wright, 2022, International journal of molecular sciences.

Vitamin D interferes with glucocorticoid responsiveness in human peripheral blood mononuclear target cells

A. Papavassiliou, E. Kassi, P. Moutsatsou, 2016, Cellular and Molecular Life Sciences.

Adhesion molecules and high‐sensitivity C‐reactive protein levels in patients with sickle cell beta‐thalassaemia

I. Papassotiriou, P. Makrythanasis, A. Kattamis, 2012, European journal of clinical investigation.

Chelation therapy in patients with thalassemia using the orally active iron chelator deferiprone (L1).

K. Konstantopoulos, V. Kalotychou, M. Karagiorga, 2000, Haematologica.

Neutrophil elastase in patients with homozygous β‐thalassemia and pseudoxanthoma elasticum‐like syndrome

D. Loukopoulos, E. Voskaridou, C. Fragodimitri, 2000, American journal of hematology.

Analysis of the A(TA)nTAA configuration in the promoter region of the UGT1 A1 gene in Greek patients with thalassemia intermedia and sickle cell disease

D. Loukopoulos, V. Kalotychou, E. Terpos, 2003 .

Analysis of the A(TA)(n)TAA configuration in the promoter region of the UGT1 A1 gene in Greek patients with thalassemia intermedia and sickle cell disease.

D. Loukopoulos, V. Kalotychou, E. Terpos, 2003, Blood cells, molecules & diseases.

Plesiomonas shigelloides Sepsis in a Thalassemia Intermedia Patient

A. Michalopoulos, C. Spiliopoulou, K. Konstantopoulos, 2002, Scandinavian journal of infectious diseases.

The Diagnostic, Prognostic and Therapeutic Role of miRNAs in Adrenocortical Carcinoma: A Systematic Review

E. Kassi, D. Delivanis, Chrysoula Mytareli, 2021, Biomedicines.

UGT1A1*28 Polymorphism in Chronic Lymphocytic Leukemia: The First Investigation of the Polymorphism in Disease Susceptibility and Its Specific Cytogenetic Abnormalities

G. Kouraklis, A. Kostakis, G. Pantelias, 2014, Acta Haematologica.

Functional role of the four different types of (AT)(x)T(y) motifs 5' to the beta-globin gene and their distribution in the Greek population.

N. Anagnou, D. Loukopoulos, E. Voskaridou, 2002, Blood cells, molecules & diseases.

Contribution of G71R mutation to Gilbert's syndrome phenotype in a Greek patient: A case report.

K. Konstantopoulos, V. Kalotychou, M. Karakosta, 2011, World journal of gastrointestinal pharmacology and therapeutics.

Erythrocytosis Due to a Combination of the High Oxygen Affinity Hemoglobin Variant, Hb Olympia [β20(B2)Val→Met] with β- and α-Thalassemia Mutations: First Case in the Literature

I. Papassotiriou, K. Konstantopoulos, V. Kalotychou, 2010, Hemoglobin.

Hereditary hyperferritinemia cataract syndrome in three unrelated families of western Greek origin caused by the C39 > G mutation of L-ferritin IRE.

I. Papassotiriou, D. Contopoulos-Ioannidis, I. Asproudis, 2006, Blood cells, molecules & diseases.

Amelioration of painful crises in sickle cell disease by venesections.

A. Aessopos, K. Konstantopoulos, P. Fessas, 2002, Blood cells, molecules & diseases.

The effect of Endothelial Nitric Oxide Synthase G894T and T786C polymorphisms on Hypoxia-Inducible Factor-1 alpha expression in Sickle Cell Disease.

K. Konstantopoulos, I. Armenis, V. Kalotychou, 2021, Nitric oxide : biology and chemistry.

Nutrition borne myolysis; an uncommon cause of myolysis in Europe

K. Konstantopoulos, V. Kalotychou, J. Rombos, 2000, Upsala journal of medical sciences.